SCHEMBL30816280

CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C

nearest known ligand 0.65

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	NPY1R	P25929	1/20	0.65

▸	NPY2R	P49146	1/20	0.65

▸	NPY4R	P50391	1/20	0.65

▸	NPY5R	Q15761	1/20	0.65

▸	CXCR4	P61073	7/20	0.62

▸	C5AR1	P21730	1/20	0.59

▸	RXFP1	Q9HBX9	1/20	0.59

▸	PTH1R	Q03431	1/20	0.59

▸	GLP1R	P43220	8/20	0.58

▸	GCGR	P47871	3/20	0.58

▸	GIPR	P48546	3/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29430205	0.98	NPY1R (0.65)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL30880883	0.93	NPY1R (0.61)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29523146	0.93	RXFP1 (0.64)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29531305	0.92	CXCR4 (0.63)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL30578720	0.91	NPY1R (0.69)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29430200	0.90	NPY2R (0.74)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL31183030	0.89	NPY1R (0.67)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL30423449	0.89	NPY2R (0.69)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29523240	0.89	MC4R (0.65)	NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL30436894	0.89	CXCR4 (0.69)	NPY1RNPY2RNPY4RNPY5RCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240059758-A1	THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST SARS-COV-2 GLYCOPROTEIN S	CORAT THERAPEUTICS GMBH (DE)	2024-02-22	—	—	US	claimed